In the research study, released in the journal Science Advances, 83 patients with an average age of 81 and all struggling with moderate to severe COVID-19 infection were given a drug called baricitinib.
Learn More
In the research study, released in the journal Science Advances, 83 patients with an average age of 81 and all struggling with moderate to severe COVID-19 infection were given a drug called baricitinib.
Learn More